Industry paid $6.5bn to US physicians and hospitals in 2014BMJ 2015; 351 doi: https://doi.org/10.1136/bmj.h3697 (Published 07 July 2015) Cite this as: BMJ 2015;351:h3697
- Michael McCarthy
Drug and medical device makers paid $6.49bn (£4.2bn; €5.9bn) to physicians and teaching hospitals in the United States last year, reported the US Centers for Medicare and Medicaid Services.1
The transactions were detailed in an open access database, called Open Payments, that provides information on more than 11.4 million financial transactions reported for the year between the industry and more than 600 000 physicians and 1100 teaching hospitals.
The Open Payments program, which was created by the 2010 Affordable Care Act, requires drug and device manufacturers to report all “transfers of value” to healthcare providers and teaching hospitals. These range from research grants to honorariums, speaking fees, travel expenses and meals, and payments …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial